The future of tumor characterization lies in the integration of multi-omics approaches, including genomics, transcriptomics, proteomics, and metabolomics, to achieve a holistic understanding of tumors. Advances in artificial intelligence and machine learning are also expected to enhance the accuracy and efficiency of tumor profiling, leading to more precise and effective cancer treatments.
